1. Home
  2. CHEB vs SRTS Comparison

CHEB vs SRTS Comparison

Compare CHEB & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHEB
  • SRTS
  • Stock Information
  • Founded
  • CHEB 2024
  • SRTS 2010
  • Country
  • CHEB Singapore
  • SRTS United States
  • Employees
  • CHEB N/A
  • SRTS N/A
  • Industry
  • CHEB
  • SRTS Medical/Dental Instruments
  • Sector
  • CHEB
  • SRTS Health Care
  • Exchange
  • CHEB NYSE
  • SRTS Nasdaq
  • Market Cap
  • CHEB 115.7M
  • SRTS 106.0M
  • IPO Year
  • CHEB 2024
  • SRTS 2016
  • Fundamental
  • Price
  • CHEB $10.06
  • SRTS $7.64
  • Analyst Decision
  • CHEB
  • SRTS Strong Buy
  • Analyst Count
  • CHEB 0
  • SRTS 2
  • Target Price
  • CHEB N/A
  • SRTS $12.00
  • AVG Volume (30 Days)
  • CHEB 1.8K
  • SRTS 164.1K
  • Earning Date
  • CHEB 01-01-0001
  • SRTS 11-14-2024
  • Dividend Yield
  • CHEB N/A
  • SRTS N/A
  • EPS Growth
  • CHEB N/A
  • SRTS N/A
  • EPS
  • CHEB N/A
  • SRTS 0.57
  • Revenue
  • CHEB N/A
  • SRTS $41,308,000.00
  • Revenue This Year
  • CHEB N/A
  • SRTS $55.14
  • Revenue Next Year
  • CHEB N/A
  • SRTS $21.75
  • P/E Ratio
  • CHEB N/A
  • SRTS $13.43
  • Revenue Growth
  • CHEB N/A
  • SRTS 65.62
  • 52 Week Low
  • CHEB $9.96
  • SRTS $2.02
  • 52 Week High
  • CHEB $26.25
  • SRTS $8.29
  • Technical
  • Relative Strength Index (RSI)
  • CHEB N/A
  • SRTS 66.58
  • Support Level
  • CHEB N/A
  • SRTS $6.70
  • Resistance Level
  • CHEB N/A
  • SRTS $6.73
  • Average True Range (ATR)
  • CHEB 0.00
  • SRTS 0.43
  • MACD
  • CHEB 0.00
  • SRTS 0.08
  • Stochastic Oscillator
  • CHEB 0.00
  • SRTS 66.49

About CHEB CHENGHE ACQUISITION II CO

Chenghe Acquisition II Co is a blank check company.

About SRTS Sensus Healthcare Inc.

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Share on Social Networks: